Pre Use Post Sterilization Integrity Testing - Considerations In Implementation
Source: CAI
By Jeff J. Gaerke, P.E., Principal Consultant

There has been significant debate over the years between regulatory agencies and the pharmaceutical industry regarding the advantages and disadvantages related to patient sterility risk with performing Pre-Use Post-Sterilization Integrity Testing (PUPSIT) of sterilizing-grade filters. This white paper will not add to this specific discussion; instead, the purpose of this document is to provide the reader with items to consider when determining how to implement PUPSIT in a robust manner for their particular application in instances where the decision is to perform PUPSIT.
access the E-Book!
Log In
Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue.
X
Enter your credentials below to log in. Not yet a member of Cell & Gene? Subscribe today.
Subscribe to Cell & Gene
X
Subscribe to Cell & Gene
This website uses cookies to ensure you get the best experience on our website. Learn more